{"url":"https://etfiq.com/compare/any/bioy-vs-xbi","section":"compare","title":"BIOY vs XBI: ETF Returns, Fees and Overlap | ETFIQ","description":"BIOY vs XBI to Oct 28, 2026: expense ratio 1.07% against 0.35%. GraniteShares YieldBOOST Biotech ETF against State Street SPDR S&P Biotech ETF.","as_of":"Oct 28, 2026","structured_data":[{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Are BIOY and XBI in the same category?","acceptedAnswer":{"@type":"Answer","text":"BIOY is an option-income ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings."}},{"@type":"Question","name":"Which is cheaper, BIOY or XBI?","acceptedAnswer":{"@type":"Answer","text":"XBI is cheaper, by 0.72 percentage points a year. That is about $72 on $10,000 held for a year. Fees come from each fund's prospectus."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Compare ETFs","item":"https://etfiq.com/compare/"},{"@type":"ListItem","position":3,"name":"BIOY vs XBI","item":"https://etfiq.com/compare/any/bioy-vs-xbi"}]},{"@type":"WebPage","name":"BIOY vs XBI: ETF Returns, Fees and Overlap","description":"BIOY vs XBI to Oct 28, 2026: expense ratio 1.07% against 0.35%. GraniteShares YieldBOOST Biotech ETF against State Street SPDR S&P Biotech ETF.","url":"https://etfiq.com/compare/any/bioy-vs-xbi","dateModified":"2026-10-28","speakable":{"@type":"SpeakableSpecification","cssSelector":[".verdict",".lede",".faq"]},"isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"}},{"@type":"Dataset","name":"ETFIQ comparison of BIOY and XBI","description":"BIOY vs XBI to Oct 28, 2026: expense ratio 1.07% against 0.35%. GraniteShares YieldBOOST Biotech ETF against State Street SPDR S&P Biotech ETF.","dateModified":"2026-10-28","creator":{"@id":"https://etfiq.com/#org"},"license":"https://etfiq.com/license/","isAccessibleForFree":true,"url":"https://etfiq.com/compare/any/bioy-vs-xbi","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Compare ETFs","item":"https://etfiq.com/compare/"},{"@type":"ListItem","position":3,"name":"BIOY vs XBI","item":"https://etfiq.com/compare/any/bioy-vs-xbi"}]},{"@type":"WebPage","name":"BIOY vs XBI: ETF Returns, Fees and Overlap","description":"BIOY vs XBI to Oct 28, 2026: expense ratio 1.07% against 0.35%. GraniteShares YieldBOOST Biotech ETF against State Street SPDR S&P Biotech ETF.","url":"https://etfiq.com/compare/any/bioy-vs-xbi","dateModified":"2026-10-28","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".verdict",".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":4758,"truncated":true,"content":"ETFIQ / Compare ETFs / BIOY vs XBI \n \n Data as of Oct 28, 2026.\n ETFIQ etfiq.com \u00b7 independent ETF data \n BIOY vs XBI: Differences, Returns & Fees\n BIOY and XBI are measured over different days, and XBI charges 0.35% to BIOY's 1.07%.\n Copy this for sharing \n XBI costs 0.72 points a year less; XBI is far larger, $10.3bn against $1.5m.\n BIOY and XBI at a glance. As of Oct 28, 2026. Source: ETFIQ. BIOY XBI \n Expense ratio 1.07% 0.35% \n Net assets, as of Oct 27, 2026 $1.5m $10.3bn \n Total return, 1 year not published +41.2% \n What it tracks Benchmark: Biotech, measured through XBI Biotech \n Holdin","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, BIOY against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/bioy-vs-xbi","a":{"ticker":"BIOY","name":"GraniteShares YieldBOOST Biotech ETF","issuer":"GraniteShares","desk":"income","as_of":"2026-10-28","verdict":"Since launch in May 2026, BIOY paid 25.2% in cash and returned 3.5% in total, against 17.8% for XBI.","url":"https://etfiq.com/funds/bioy","key_facts":[{"label":"Cash paid, since launch, on its starting price","value":"25.2%","as_of":"2026-10-28","source":"computed by ETFIQ from Tiingo daily prices and distributions"},{"label":"Total return, since launch","value":"+3.5%","as_of":"2026-10-28","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Against XBI","value":"\u221214.3 pts","as_of":"2026-10-28","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"Return of capital, latest payout (GraniteShares estimate)","value":"96.3%","as_of":"2026-10-28","source":"GraniteShares estimate"},{"label":"Last payment (paid weekly), ex-date Oct 23, 2026","value":"$0.2263","as_of":"2026-10-23","source":"Tiingo end-of-day distributions"},{"label":"Net assets","value":"$1.5m","as_of":"2026-10-27","source":"issuer page, as of Oct 27, 2026"},{"label":"Expense ratio","value":"1.07%","as_of":"2025-10-27","source":"497 XBRL, Oct 27, 2025"}]},"b":{"ticker":"XBI","name":"State Street SPDR S&P Biotech ETF","issuer":"State Street","desk":"themes","as_of":"2026-10-28","verdict":"Over the year to Oct 28, 2026, XBI returned 41.2%.","url":"https://etfiq.com/funds/xbi","key_facts":[{"label":"Already in the S&P 500","value":"13.2%","as_of":"2026-10-27","source":"the issuer\u2019s daily holdings file"},{"label":"Active share vs the S&P 500","value":"98.4%","as_of":"2026-10-27","source":"ETFIQ"},{"label":"Top ten holdings","value":"17.8%","as_of":"2026-10-27","source":"the issuer\u2019s daily holdings file"},{"label":"Total return, 1 year","value":"+41.2%","as_of":"2026-10-28","source":"computed by ETFIQ from Tiingo daily prices"},{"label":"12-month yield, capital gains included, on its starting price","value":"0.5%","as_of":"2026-10-28","source":"computed by ETFIQ from Tiingo daily prices and distributions"},{"label":"Last payment (paid quarterly), ex-date Jun 22, 2026","value":"$0.1381","as_of":"2026-06-22","source":"Tiingo end-of-day distributions"},{"label":"Net assets","value":"$10.3bn","as_of":"2026-10-27","source":"the issuer\u2019s own daily fund list, as of Oct 27, 2026"},{"label":"Expense ratio","value":"0.35%","as_of":"2025-10-24","source":"485BPOS XBRL, Oct 24, 2025"}]},"overlap_pct":0,"full_text_at":"https://etfiq.com/compare/any/bioy-vs-xbi"}